Myocardial perfusion imaging laboratory efficiency with the use of regadenoson compared to adenosine and dipyridamole.
OBJECTIVE
Adenosine, dipyridamole, and regadenoson are pharmacologic stress agents used in myocardial perfusion imaging (MPI), to diagnose and monitor coronary artery disease. Clinical studies suggest that regadenoson has pharmacologic properties that simplify the MPI procedure through availability to a wider range of patients and easier administrative requirements. This study assesses the operational advantages and laboratory efficiency associated with the use of regadenoson compared to adenosine and dipyridamole.


METHODS
A web-based survey of 141 nuclear medicine technologists working in US-based cardiovascular imaging laboratories from June-July 2009.


METHODS
Descriptive statistics measured the adenosine, dipyridamole, and regadenoson cohorts. Bivariate analyses compared the overall and staff-specific time to conduct an MPI test. The site-specific sub-groups were defined by hospital vs non-hospital setting, hours of operation, number of SPECT cameras, and number of full-time equivalent staff, including nurses, nuclear technologists, physicians, and nurse practitioners/physician assistants.


RESULTS
The total time to conduct an MPI test was shortest with regadenoson 156 (46) min compared to adenosine and dipyridamole 182 (63) and 191 (61) min, respectively. Time from regadenoson administration to the start of the imaging session, including dose calculation and infusion time, was 14.2 min less than adenosine, and 12.0 min less than dipyridamole. The time to manage adverse events was shortest if it occurred with regadenoson compared to adenosine and dipyridamole, with minor exceptions. Due to the nature of survey implementation, possible recall bias may limit the results. Some differences in procedures times may be attributable to differences in laboratories' protocols.


CONCLUSIONS
Overall time savings and time savings stratified by operational ability (number of staff, number of SPECT cameras, hours of operation) translate to a more efficient utilization of laboratory resources when using regadenoson compared to adenosine and dipyridamole. Regadenoson is the most efficient pharmacologic stress agent compared to adenosine and dipyridamole.
United BioSource Corporation, Lexington, MA, USA.
Michelle
M
Friedman
James
J
Spalding
Smita
S
Kothari
You
Y
Wu
Elyse
E
Gatt
Luke
L
Boulanger
D000241:Adenosine / Q000008:administration & dosage / Q000494:pharmacology; D003324:Coronary Artery Disease / Q000175:diagnosis*; D003625:Data Collection; D004176:Dipyridamole / Q000008:administration & dosage / Q000494:pharmacology; D006282:Health Personnel / Q000706:statistics & numerical data; D006801:Humans; D055414:Myocardial Perfusion Imaging / Q000379:methods*; D009684:Nuclear Medicine Department, Hospital; D011687:Purines / Q000008:administration & dosage / Q000494:pharmacology; D011720:Pyrazoles / Q000008:administration & dosage / Q000494:pharmacology; D043705:Receptor, Adenosine A2A / Q000187:drug effects; D013997:Time Factors; D015899:Tomography, Emission-Computed, Single-Photon; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000494:pharmacology
D011687:Purines; D011720:Pyrazoles; D043705:Receptor, Adenosine A2A; D014665:Vasodilator Agents; C430916:regadenoson; D004176:Dipyridamole; D000241:Adenosine